Referensi Tuberkulosis T-Z

1. Tariq, M., Zafar, S., Waheed, A., Afzal, N., Razzaq, R. and Batool, F., 2023. Prevalence of Various Forms of Active Tuberculosis in Patients with Diabetes. THE THERAPIST (Journal of Therapies & Rehabilitation Sciences), pp.33-37.
2. Taylor, J., Bastos, M.L., Lachapelle-Chisholm, S., Mayo, N.E., Johnston, J. and Menzies, D., 2023. Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis. EClinicalMedicine, 59.
3. Teo, A.K.J., Morishita, F., Islam, T., Viney, K., Ong, C.W., Kato, S., Kim, H., Liu, Y., Oh, K.H., Yoshiyama, T. and Ohkado, A., 2023. Tuberculosis in older adults: challenges and best practices in the Western Pacific Region. The Lancet Regional Health-Western Pacific, 36, p.100770.
4. Thipkrua, N., Disrathakit, A., Chongsuvivatwong, V., Mahasirimongkol, S., Ruangchai, W., Palittapongarnpim, P., Chaiprasert, A., Pungrassami, P., Kamolwat, P., Suthum, K. and Tossapornpong, K., 2025. A large geno-spatial cluster of multi-drug resistant tuberculosis outbreak in a western district of Thailand. Infection, Genetics and Evolution, 128, p.105715.
5. Trevisi, L., Brooks, M.B., Becerra, M.C., Calderón, R.I., Contreras, C.C., Galea, J.T., Jimenez, J., Lecca, L., Yataco, R.M., Tovar, X. and Zhang, Z., 2024. Who transmits tuberculosis to whom: a cross-sectional analysis of a cohort study in Lima, Peru. American Journal of Respiratory and Critical Care Medicine, 210(2), pp.222-233.
6. Ugwu, C.I., Chukwulobelu, U., Igboekwu, C., Emodi, N., Anumba, J.U., Ugwu, S.C., Ezeobi, C.L., Ibeziako, V. and Nwakaogor, G.U., 2021. Geo-spatial mapping of tuberculosis burden in Anambra State, South-East Nigeria. Journal of Tuberculosis Research, 9(01), p.51.
7. Ullah, W., Wali, A., Haq, M.U., Yaqoob, A., Fatima, R. and Khan, G.M., 2021. Public–private mix models of tuberculosis care in Pakistan: a high-burden country perspective. Frontiers in public health, 9, p.703631.
8. Vaishya R, Misra A, Vaish A, Singh SK. Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges. J Diabetes. 2024 May;16(5):e13427.
9. van Crevel, R.; Critchley, J.A. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice. Trop. Med. Infect. Dis. 2021, 6, 8.
10. Van Wyk, S.S., Lin, H.H. and Claassens, M.M., 2017. A systematic review of prediction models for prevalent pulmonary tuberculosis in adults. The International Journal of Tuberculosis and Lung Disease, 21(4), pp.405-411.
11. Vesga, J.F., Hallett, T.B., Reid, M.J., Sachdeva, K.S., Rao, R., Khaparde, S., Dave, P., Rade, K., Kamene, M., Omesa, E. and Masini, E., 2019. Assessing tuberculosis control priorities in high-burden settings: a modelling approach. The Lancet Global Health, 7(5), pp.e585-e595.
12. Viswanathan, V., Devarajan, A., Kumpatla, S., Dhanasekaran, M., Babu, S. and Kornfeld, H., 2023. Effect of prediabetes on tuberculosis treatment outcomes: A study from South India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 17(7), p.102801.
13. Wang C-A, Chen C-H, Hsieh W-C, Hsu T-J, Hsu C-Y, Cheng Y-C, Hsu C-Y. Risk of Herpes Zoster in Patients with Pulmonary Tuberculosis—A Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 2023; 20(3):2656.
14. Wang C, Yang X, Zhang H, Zhang Y, Tao J, Jiang X and Wu C (2023) Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis. Front. Public Health 11:1225931.
15. Wang, J., Yu, L., Yang, Z., Shen, P., Sun, Y., Shui, L., Tang, M., Jin, M., Chen, B., Ge, Y. and Lin, H., 2025. Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern China. International journal of epidemiology, 54(2), p.dyae174.
16. Wang, M.C. and Cervantes, J., 2019. Glycemic control in tuberculosis: lessons learned from Taiwan. Asian Pacific Journal of Tropical Medicine, 12(10), pp.438-441.
17. Wang, S., Gu, R., Ren, P., Chen, Y., Wu, D. and Li, L., 2025. Prediction of tuberculosis-specific mortality for older adult patients with pulmonary tuberculosis. Frontiers in Public Health, 12, p.1515867.
18. Wang, Y., Shi, J., Yin, X., Tao, B., Shi, X., Mao, X., Wen, Q., Xue, Y. and Wang, J., 2024. The impact of diabetes mellitus on tuberculosis recurrence in Eastern China: a retrospective cohort study. BMC Public Health, 24(1), p.2534.
19. Wati, N., Mu’awanah, I.A.U. and Amalia, A.A., 2024. Pulmonary Tuberculosis Incidence Rate with Genexpert Examination Method at Mlati II Public Health Center, Sleman In 2020-2023. International Journal of Health, Economics, and Social Sciences, 6(4), pp.1124-1129.
20. Webber, T., Ronacher, K., Conradie-Smit, M. and Kleynhans, L., 2022. Interplay between the immune and endocrine systems in the lung: implications for TB susceptibility. Frontiers in immunology, 13, p.829355.
21. Wells, W.A., Waseem, S. and Scheening, S., 2024. The intersection of TB and health financing: defining needs and opportunities. IJTLD open, 1(9), pp.375-383.
22. Widihastuti, A., Sirait, R.H., Simatupang, A. and Idhayu, A.T., 2023. Effect of Poor Glycemic Control with Length of Pulmonary Tuberculosis Treatment in Type 2 Diabetes Mellitus Patients. Jurnal Farmasi Klinik Indonesia, 12(1), pp.1-10.
23. Williams, V., Onwuchekwa, C., Vos, A.G., Grobbee, D.E., Otwombe, K. and Klipstein-Grobusch, K., 2022. Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981-2021. Global Health Action, 15(1), p.2114146.
24. Wright K. Tackling Tuberculosis: The Current Landscape and Future Directions. EMJ Microbiol Infect Dis. 2025;6[1]:26-30.
25. Wulandari, D.A., Hartati, Y.W., Ibrahim, A.U. and Pitaloka, D.A.E., 2024. Multidrug-resistant tuberculosis. Clinica Chimica Acta, 559, p.119701.
26. Xiao, J., Ge, J., Zhang, D., Lin, X., Wang, X., Peng, L. and Chen, L., 2022. Clinical characteristics and outcomes in chronic kidney disease patients with tuberculosis in China: A retrospective cohort study. International Journal of General Medicine, 15, p.6661.
27. Xiong, X.S., Zhang, X.D., Yan, J.W., Huang, T.T., Liu, Z.Z., Li, Z.K., Wang, L. and Li, F., 2024. Identification of Mycobacterium tuberculosis resistance to common antibiotics: an overview of current methods and techniques. Infection and Drug Resistance, pp.1491-1506.
28. Xu, G., Hu, X., Lian, Y. and Li, X., 2023. Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases, 23(1), p.813.
29. Yamanaka, T., Castro, M.C., Ferrer, J.P., Solon, J.A., Cox, S.E., Laurence, Y.V. and Vassall, A., 2024. Health system costs of providing outpatient care for diabetes in people with TB in the Philippines. IJTLD open, 1(3), pp.124-129.
30. Yang, C.C., Shih, Y.J., Ayles, H., Godfrey-Faussett, P., Claassens, M. and Lin, H.H., 2024. Cost-effectiveness analysis of a prediction model for community-based screening of active tuberculosis. Journal of Global Health, 14, p.04226.
31. Yang, Y.J., Pan, S.C., Lee, M.R., Chung, C.L., Ku, C.P., Liao, C.Y., Tsai, T.Y., Wang, J.Y., Fang, C.T. and Chen, Y.C., 2024. Quantifying the contribution of smear-negative, culture-positive pulmonary tuberculosis to nosocomial transmission. American Journal of Infection Control, 52(7), pp.807-812.
32. Yang, B.R., Kang, Y.A., Heo, E.Y., Koo, B.K., Choi, N.K., Hwang, S.S. and Lee, C.H., 2018. Regional differences in the incidence of tuberculosis among patients with newly diagnosed diabetes mellitus. The Clinical Respiratory Journal, 12(4), pp.1732-1738.
33. Yanqiu X, Yang Y, Xiaoqing W, Zhixuan L, Kuan Z, Xin G, Bo Z, Jinyu W, Jing C, Yan M, Aiguo M. Impact of hyperglycemia on tuberculosis treatment outcomes: a cohort study. Scientific Reports. 2024 Jun 12;14(1):13586.
34. Ye, Z., Li, L., Yang, L., Zhuang, L., Aspatwar, A., Wang, L. and Gong, W., 2024. Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective. In Exploration (p. 20230138).
35. Yoo JE, Kim D, Han K, Rhee SY, Shin DW, Lee H. Diabetes status and association with risk of tuberculosis among Korean adults. JAMA network open. 2021 Sep 1;4(9):e2126099.
36. Yu, X., Li, L., Xia, L., Feng, X., Chen, F., Cao, S. and Wei, X., 2019. Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review. BMC infectious diseases, 19, pp.1-11.
37. Zayar, N.N., Chotipanvithayakul, R., Bjertness, E., Htet, A.S., Geater, A.F. and Chongsuvivatwong, V., 2023. Vulnerability of NCDs and Mediating Effect of Risk Behaviors Among Tuberculosis Patients and Their Household Contacts Compared to the General Population in the Yangon Region, Myanmar. International Journal of General Medicine, pp.5909-5920.
38. Zelner, J.L., Murray, M.B., Becerra, M.C., Galea, J., Lecca, L., Calderon, R., Yataco, R., Contreras, C., Zhang, Z., Manjourides, J. and Grenfell, B.T., 2016. Identifying hotspots of multidrug-resistant tuberculosis transmission using spatial and molecular genetic data. The Journal of infectious diseases, 213(2), pp.287-294.
39. Zhang, X., Chen, P. and Xu, G., 2022. Update of the mechanism and characteristics of tuberculosis in chronic kidney disease. Wiener klinische Wochenschrift, 134(13), pp.501-510.
40. Zhang, C., Liu, Y., Yao, Y., Gong, D., Lei, R., Xia, Y., Xu, C., Chen, H., Cheng, J. and Zhang, H., 2024. Tuberculosis infection among close contacts of patients with pulmonary tuberculosis in China: a population-based, multicentered study. Clinical Microbiology and Infection, 30(9), pp.1176-1182.
41. Zhao, L., Fan, K., Sun, X., Li, W., Qin, F., Shi, L., Gao, F. and Zheng, C., 2024. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus. Frontiers in Immunology, 14, p.1305325.
42. Zhao, L., Gao, F., Zheng, C. and Sun, X., 2024. The impact of optimal glycemic control on tuberculosis treatment outcomes in patients with diabetes mellitus: systematic review and meta-analysis. JMIR Public Health and Surveillance, 10, p.e53948.
43. Zheng, C., Hu, M. and Gao, F., 2017. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Global health action, 10(1), p.1264702.
44. Zhou, G., Guo, X., Cai, S., Zhang, Y., Zhou, Y., Long, R., Zhou, Y., Li, H., Chen, N. and Song, C., 2023. Diabetes mellitus and latent tuberculosis infection: an updated meta-analysis and systematic review. BMC Infectious Diseases, 23(1), p.770.

 

Referensi Tuberkulosis N-Q

  

1. Ngo, M.D.; Bartlett, S.; Ronacher, K. Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia. Microorganisms 2021, 9, 2282.
2. Nguyen, T.A., Teo, A.K.J., Zhao, Y., Quelapio, M., Hill, J., Morishita, F., Marais, B.J. and Marks, G.B., 2024. Population-wide active case finding as a strategy to end TB. The Lancet regional health. Western Pacific, 46, p.101047.
3. Njiro, B.J., Kisonga, R., Joachim, C., Sililo, G.A., Nkiligi, E., Ibisomi, L., Chirwa, T. and Francis, J.M., 2024. Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset. PLOS Neglected Tropical Diseases, 18(2), p.e0011968.
4. Nugrahaeni, D.K., Kusumasari, I., Budiana, T.A., and Mauliku, N.E. (2025). Factors Associated with Tuberculosis-Diabetes Mellitus Comorbidity. Periodic Epidemiology Journal/Jurnal Berkala Epidemiologi, 13(1):75-84.
5. Nuraisyah, F., Juliana, N., Astaria, D., Khalisah, N., Al Fatih, D.M.F., Dewi, S.K. and Marwati, T., 2024. Risk Factors of Pulmonary Tuberculosis in Type 2 Diabetes Mellitus in Yogyakarta. Journal of Epidemiology and Public Health, 9(2), pp.194-203.
6. Ockenga, J., Fuhse, K., Chatterjee, S., Malykh, R., Rippin, H., Pirlich, M., Yedilbayev, A., Wickramasinghe, K. and Barazzoni, R., 2023. Tuberculosis and malnutrition: the European perspective. Clinical Nutrition, 42(4), pp.486-492.
7. Oliveira Hashiguchi, L., Cox, S.E., Edwards, T. et al. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Serv Res 23, 1027 (2023). https://doi.org/10.1186/s12913-023-10015-7.
8. Oliveira Hashiguchi, L., Ferrer, J.P., Suzuki, S., Faguer, B.N., Solon, J.A., Castro, M.C., et al. (2024). Glycemic control during TB treatment among Filipinos: The Starting Anti-Tuberculosis Treatment Cohort Study. PLOS Global Public Health, 4(5), e0003156. 
9. Omar, N., Wong, J., Thu, K., Alikhan, M.F. and Chaw, L., 2021. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Brunei Darussalam: a 6-year retrospective cohort study. International Journal of Infectious Diseases, 105, pp.267-273.
10. Oxlade, O., Benedetti, A., Adjobimey, M., Alsdurf, H., Anagonou, S., Cook, V.J., Fisher, D., Fox, G.J., Fregonese, F., Hadisoemarto, P. and Hill, P.C., 2021. Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. The Lancet Public Health, 6(5), pp.e272-e282.
11. Pan, S.C., Ku, C.C., Kao, D., Ezzati, M., Fang, C.T. and Lin, H.H., 2015. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. The lancet Diabetes & endocrinology, 3(5), pp.323-330.
12. Pan S-C, Chen Y-C, Wang J-Y, Sheng W-H, Lin H-H, Fang C-T, et al. (2015) Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan. PLoS ONE 10(12): e0145047.
13. Pan, S.C., Chen, C.C., Chiang, Y.T., Chang, H.Y., Fang, C.T. and Lin, H.H., 2016. Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case–control study. American journal of public health, 106(7), pp.1323-1328.
14. Pando, C., Hazel, A., Tsang, L.Y., Razafindrina, K., Andriamiadanarivo, A., Rabetombosoa, R.M., Ambinintsoa, I., Sadananda, G., Small, P.M., Knoblauch, A.M. and Rakotosamimanana, N., 2023. A social network analysis model approach to understand tuberculosis transmission in remote rural Madagascar. BMC Public Health, 23(1), p.1511.
15. Pardeshi, G., Mave, V., Gaikwad, S., Kadam, D., Barthwal, M., Gupte, N., Atre, S., Deshmukh, S., Golub, J.E. and Gupte, A., 2024. Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India: A Prospective Cohort Study. Chest, 165(2), pp.278-287.
16. Park, S.W., Shin, J.W., Kim, J.Y., Park, I.W., Choi, B.W., Choi, J.C. and Kim, Y.S., 2012. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. European journal of clinical microbiology & infectious diseases, 31, pp.1305-1310.
17. Patel, D.G., Baral, T., Kurian, S.J., Malakapogu, P., Saravu, K. and Miraj, S.S., 2024. Nutritional status in patients with tuberculosis and diabetes mellitus: A comparative observational study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 35, p.100428.
18. Peng, Y.F., 2023. Pulmonary tuberculosis and diabetes mellitus: Epidemiology, pathogenesis and therapeutic management. Medicine International, 4(1), p.1-4.
19. Penyami, Y., Angkasa, M.P. and Sumarni, S., 2025. Using storybooks to enhance health awareness among schoolchildren at risk of tuberculosis. Malahayati International Journal of Nursing and Health Science, 7(11), pp.1338-1343.
20. Petruccioli, E., Scriba, T.J., Petrone, L., Hatherill, M., Cirillo, D.M., Joosten, S.A., Ottenhoff, T.H., Denkinger, C.M. and Goletti, D., 2016. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. European Respiratory Journal, 48(6), pp.1751-1763.
21. Pradana, T.L.C., Putra, B.T.W. and Utami, W.S., 2025. Stigma Tuberkulosis Paru di Asia Tenggara: Systematic Literatur Review. MAHESA: Malahayati Health Student Journal, 5(6), pp.2501-2512.
22. Pramono, J.S., Ridwan, A., Maria, I.L., Syam, A., Russeng, S.S. and Mumang, A.A., 2024. Active case finding for tuberculosis in migrants: a systematic review. Medical Archives, 78(1), p.60.
23. Pratiwi, R.D., Alisjahbana, B., Subronto, Y.W., Priyanta, S. and Suharna, S., 2025. Implementation of an information system for tuberculosis in healthcare facilities in Indonesia: evaluation of its effectiveness and challenges. Archives of Public Health, 83(1), pp.1-18.
24. Puyat, J.H., Brode, S.K., Shulha, H., Romanowski, K., Menzies, D., Benedetti, A., Duchen, R., Huang, A., Fang, J., Macdonald, L. and Marras, T.K., 2025. Predicting Risk of Tuberculosis (TB) Disease in People Who Migrate to a Low-TB Incidence Country: Development and Validation of a Multivariable, Dynamic Risk-Prediction Model Using Health Administrative Data. Clinical Infectious Diseases, 80(3), pp.644-652.
25. Qi, M., Qiao, R. and He, J.Q., 2025. The association between triglyceride-glucose index and related parameters and risk of tuberculosis infection in American adults under different glucose metabolic states: a cross-sectional study. BMC Public Health, 25(1), pp.1-11.
26. Qi, X., Yang, Q., Cai, J., Wu, J., Gao, Y., Ruan, Q., Shao, L., Liu, J., Zhou, X., Zhang, W. and Jiang, N., 2024. Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination. Emerging Microbes & Infections, 13(1), p.2295387.

Referensi Tuberkulosis G-K

 See also: https://yosephsamodra.com

1. Galán, M.D.M.D., Redondo-Bravo, L., Gómez-Barroso, D., Herrera, L., Amillategui, R., Gómez-Castellá, J. and Herrador, Z., 2024. The impact of meteorological factors on tuberculosis incidence in Spain: a spatiotemporal analysis. Epidemiology & Infection, 152, p.e58.
2. Galib, R.K., Paul, S.K., Akter, K., Musa, M.I., Sarker, D.J., Choudhury, S.A.R.A., Paul, S.C. and Chakrabortty, R., 2025. Frequency of Lower Lung Field Tuberculosis in Diabetes Mellitus Patients Attending Tertiary Care Hospital in Bangladesh: A Cross‐Sectional Study. Health Science Reports, 8(1), p.e70413.
3. Gebreweld, A., Fiseha, T., Kebede, E., Tamir, Z., Gebremariam, B., Miruts, F. and Haileslasie, H., 2024. Immuno-Hematological and Biochemical Changes in Patients with Tuberculosis in Dessie Comprehensive Specialized Hospital, Dessie, Ethiopia. Journal of Blood Medicine, pp.147-155.
4. Giridharan, P., Suseela, R.P., Zangpo, T., Joshi, R.B., Cader, M., Isbaniah, F., Velayudham, B., Rafeeg, F.N., da Cruz Santos, A., Shah, N.P. and Mathew, M., 2024. Tuberculosis preventive treatment in eight SEAR countries–Current practices, implementation challenges and operations research priorities. Public Health in Practice, 8, p.100518.
5. Godoy, S., Parrón, I., Millet, J.P., Caylà, J.A., Follia, N., Carol, M., Orcau, A., Alsedà, M., Toledo, D., Plans, P. and Ferrús, G., 2024. Risk of tuberculosis among pulmonary tuberculosis contacts: the importance of time of exposure to index cases. Annals of Epidemiology, 91, pp.12-17.
6. Goletti, D., Pisapia, R., Fusco, F.M., Aiello, A. and Van Crevel, R., 2023. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes. The International Journal of Tuberculosis and Lung Disease, 27(4), pp.284-290.
7. Guillén, S.M., et al., 2023. Tuberculosis in Spain: An opinion paper. Rev Esp Quimioter, 36(6), pp.562-583.
8. Gupta-Wright, Ankur, Huy Ha, Shima Abdulgadar, Rebecca Crowder, Jerusha Emmanuel, Job Mukwatamundu, Danaida Marcelo et al. "Evaluation of the Xpert MTB Host Response assay for the triage of patients with presumed pulmonary tuberculosis: a prospective diagnostic accuracy study in Viet Nam, India, the Philippines, Uganda, and South Africa." The Lancet Global Health 12, no. 2 (2024): e226-e234.
9. Gurumurthy, M., Gopalan, N., Patel, L., Davis, A., Srinivasalu, V.A., Rajaram, S., Goodall, R., Bronson, G. and STREAM Trial Collaboration, 2025. Treatment outcomes in people with diabetes and multidrug-resistant tuberculosis (MDR TB) enrolled in the STREAM clinical trial. PLOS Global Public Health, 5(4), p.e0004259.
10. Habib, M.A., Afrin, K., Efa, S.S., Hossain, M.D., Islam, M.R., Rahman, M.M., Islam, N., Afroz, F., Rahim, M.A. and Hossain, M.D., 2024. Effects of diabetes mellitus on retreatment of Tuberculosis: A multi-centered case-control study from Bangladesh. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 36, p.100450.
11. Hakam, M.A., Safitri, B.D., Wandastuti, A.D., Husni, M.F., Setiawan, A.W., Konoralma, A.R., Radja, B.L., Setiono, O. and Wulan, W.R., 2024. The Relationship Between Adequate Housing And Household Sanitation With The Success Of Tuberculosis Patient Treatment In Semarang City. International Journal of Health Literacy and Science, 2(2), pp.14-19.
12. Hamada, Y., Quartagno, M., Law, I., Malik, F., Bonsu, F.A., Adetifa, I.M., Adusi-Poku, Y., D'Alessandro, U., Bashorun, A.O., Begum, V. and Lolong, D.B., 2023. Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys. EClinicalMedicine, 63.
13. Hamada, Y., Lugendo, A., Ntshiqa, T., Kubeka, G., Lalashowi, J.M., Mwastaula, S., Ntshamane, K., Sabi, I., Wilson, S., Copas, A. and Velen, K., 2024. A pilot cross-sectional study of non-communicable diseases in TB household contacts. IJTLD OPEN, 1(4), pp.154-159.
14. Handayani, S. and Isworo, S., 2024. Evaluation of Tuberculosis program implementation in Primary Health Care, Semarang, Indonesia. International Journal of Public Health Asia Pacific, pp.1-11.
15. Harahap, E.C.L., Purwanti, A. and Hardianto, N., 2024. Perbedaan Proporsi Sputum Bakteri Tahan Asam Positif pada Pasien Diabetes Melitus Terkendali dan Tidak Terkendali. Jurnal Laboratorium Khatulistiwa, 8(1), pp.168-180.
16. Hariyanto, S.W., Avidati, H., Ulfah, U., Nurlaily, A.N. and Tejaningrum, K.D., Tuberculosis Screening in Patients with Diabetes Mellitus at the Internal Medicine Clinic of UGM Academic Hospital: Descriptive Study. Academic Hospital Journal, 7(1), p.8.
17. Herman, D., Machmud, R. and Lipoeto, N.I., 2025. Unraveling the Link between Obesity and Tuberculosis: A Systematic Review of the Underlying Mechanisms. Bioscientia Medicina: Journal of Biomedicine and Translational Research, 9(2), pp.6453-6466.
18. Hong, K.J., Wang, T.C. and Tsui, K., 2025. Association of acid-suppressive therapy and tuberculosis: A causal or coincidental link to the infection?. Respiratory Investigation, 63(1), pp.27-32.
19. Houben, R.M., Menzies, N.A., Sumner, T., Huynh, G.H., Arinaminpathy, N., Goldhaber-Fiebert, J.D., Lin, H.H., Wu, C.Y., Mandal, S., Pandey, S. and Suen, S.C., 2016. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet Global Health, 4(11), pp.e806-e815.
20. Huang, F. and Bello, S.T., 2024. Spatiotemporal analysis of regional and age differences in tuberculosis prevalence in mainland China. Tropical Medicine & International Health, 29(9), pp.833-841.
21. Huang, H.L., Huang, W.C., Lin, K.D., Liu, S.S., Lee, M.R., Cheng, M.H., Chin, C.S., Lu, P.L., Sheu, C.C., Wang, J.Y. and Lee, I.T., 2021. Completion rate and safety of programmatic screening and treatment for latent tuberculosis infection in elderly patients with poorly controlled diabetic mellitus: a prospective multicenter study. Clinical Infectious Diseases, 73(6), pp.e1252-e1260.
22. Huang, Y.W., Yu, M.C., Lin, C.B., Lee, J.J., Lin, C.J., Chien, S.T., Lee, C.H. and Chiang, C.Y., 2024. Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs. Journal of Microbiology, Immunology and Infection, 57(4), pp.617-628.
23. Innes, A.L., Lebrun, V., Hoang, G.L., Martinez, A., Dinh, N., Nguyen, T.T.H., Huynh, T.P., Quach, V.L., Nguyen, T.B., Trieu, V.C. and Tran, N.D.B., 2024. An effective health system approach to end TB: implementing the double X strategy in Vietnam. Global Health: Science and Practice, 12(3).
24. Iskandar, D., Suwantika, A.A., Pradipta, I.S., Postma, M.J. and van Boven, J.F., 2023. Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017–19. The Lancet Global Health, 11(1), pp.e117-e125.
25. Ismail, Nazir, Harry Moultrie, Judith Mwansa-Kambafwile, Andrew Copas, Alane Izu, Sizulu Moyo, Donald Skinner et al. "Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial." The Lancet Infectious Diseases (2025).
26. Jagger, P., McCord, R., Gallerani, A., Hoffman, I., Jumbe, C., Pedit, J., Phiri, S., Krysiak, R. and Maleta, K., 2024. Household air pollution exposure and risk of tuberculosis: a case–control study of women in Lilongwe, Malawi. BMJ Public Health, 2(1).
27. Jeong D, et al. Prevalence and associated factors of diabetes mellitus among patients with tuberculosis in South Korea from 2011 to 2018: a nationwide cohort study. BMJ Open 2023;13:e069642.
28. Jesus, G.S., Gestal, P.F., Silva, A.F., Cavalcanti, D.M., Lua, I., Ichihara, M.Y., Barreto, M.L., Boccia, D., Sanchez, M.N. and Rasella, D., 2025. Effects of conditional cash transfers on tuberculosis incidence and mortality according to race, ethnicity and socioeconomic factors in the 100 Million Brazilian Cohort. Nature Medicine, pp.1-10.
29. Jiang, Y., Zhang, W., Wei, M., Yin, D., Tang, Y., Jia, W., Wang, C., Guo, J., Li, A. and Gong, Y., 2024. Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional mendelian randomization study. Diabetology & Metabolic Syndrome, 16(1), pp.1-9.
30. Kamui, I. N. (2025). Determinants of tuberculosis medication adherence among TB patients at Kiambu Level Five Hospital, Kiambu County, Kenya. Journal of Medical and Health Sciences, 4(1), 1–15.
31. Kang, J.Y., Han, K., Lee, S.H. and Kim, M.K., 2023. Diabetes severity is strongly associated with the risk of active tuberculosis in people with type 2 diabetes: a nationwide cohort study with a 6-year follow-up. Respiratory Research, 24(1), pp.1-9.
32. Kang, Y.A., Kim, S.Y., Jo, K.W., Kim, H.J., Park, S.K., Kim, T.H., Kim, E.K., Lee, K.M., Lee, S.S., Park, J.S. and Koh, W.J., 2014. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis. Respiration, 86(6), pp.472-478.
33. Kaur, R., Egli, T., Paynter, J., Murphy, R., Perumal, L., Lee, A., Harrison, A., Christmas, T., Lewis, C. and Nisbet, M., 2023. Tuberculosis and diabetes: increased hospitalisations and mortality associated with renal impairment. Internal Medicine Journal, 53(9), pp.1588-1594.
34. Khairunnisa C, Mardiati, Millizia A, Wahyuni S, Nabilah Lubis P, Ikhsan M. Risk Factors for Pulmonary Tuberculosis Transmission Among Prisoner in Correctional Facilities in Lhokseumawe City, Aceh, Indonesia. Natl J Community Med 2025;16(6):582-588.
35. Khalid N, Ahmad F, Qureshi FM. Association amid the comorbidity of Diabetes Mellitus in patients of Active Tuberculosis in Pakistan: A matched case control study. Pak J Med Sci. 2021;37(3):816-820.
36. Khan, P.Y., Paracha, M.S., Grundy, C., Madhani, F., Saeed, S., Maniar, L., Dojki, M., Page-Shipp, L., Khursheed, N., Rabbani, W. and Riaz, N., 2024. Insights into tuberculosis burden in Karachi, Pakistan: A concurrent adult tuberculosis prevalence and child Mycobacterium tuberculosis infection survey. PLOS global public health, 4(8), p.e0002155.
37. Khanna, A., Saha, R. and Ahmad, N., 2023. National TB elimination programme-what has changed. Indian Journal of Medical Microbiology, 42, pp.103-107.
38. Khattak M, et al. (2024). Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis, Annals of Medicine, 56:1, 2313683.
39. Kibirige, D., Andia-Biraro, I., Olum, R., Adakun, S., Zawedde-Muyanja, S., Sekaggya-Wiltshire, C. and Kimuli, I., 2024. Tuberculosis and diabetes mellitus comorbidity in an adult Ugandan population. BMC Infectious Diseases, 24(1), p.242.
40. Kibirige, D., Andia-Biraro, I., Kyazze, A.P., Olum, R., Bongomin, F., Nakavuma, R.M., Ssekamatte, P., Emoru, R., Nalubega, G., Chamba, N. and Kilonzo, K., 2023. Burden and associated phenotypic characteristics of tuberculosis infection in adult Africans with diabetes: a systematic review. Scientific Reports, 13(1), p.19894.
41. Kim, S.H., Park, Y.M., Han, K., Ko, S.H., Kim, S.Y., Song, S.H., Kim, C.H., Hur, K.Y. and Kim, S.K., 2022. Association of weight change following smoking cessation with the risk of tuberculosis development: A nationwide population-based cohort study. Plos one, 17(4), p.e0266262.
42. Kim KH, Kim HW, Kim YH, Park Y, Jung SS, Kim JW, et al. Effect of complicated, untreated and uncontrolled diabetes and pre-diabetes on treatment outcome among patients with pulmonary tuberculosis. Respirology. 2024; 29(7): 624–632.
43. Kirimi, E.M., Muthuri, G.G., Ngari, C.G. and Karanja, S., 2024. A Model for the Propagation and Control of Pulmonary Tuberculosis Disease in Kenya. Discrete Dynamics in Nature and Society, 2024(1), p.5883142.
44. Ko, T.H., Chang, Y.C., Chang, C.H., Liao, K.C.W., Magee, M.J. and Lin, H.H., 2023. Prediabetes and risk of active tuberculosis: a cohort study from Northern Taiwan. International Journal of Epidemiology, 52(3), pp.932-941.
45. Kobayashi, S., Yoshiyama, T., Uchimura, K., Hamaguchi, Y. and Kato, S., 2021. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination. Scientific Reports, 11(1), p.15902.
46. Kornfeld, H., Procter-Gray, E., Kumpatla, S., Kane, K., Li, W., Magee, M.J., Babu, S. and Viswanathan, V., 2023. Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment. Diabetes Research and Clinical Practice, 196, p.110242.
47. Krishnamoorthy, Y., Nagarajan, R., Rajaa, S., Majella, M.G., Murali, S. and Jayaseelan, V., 2021. Progress of South East Asian Region countries towards achieving interim End TB Strategy targets for TB incidence and mortality: a modelling study. Public Health, 198, pp.9-16.
48. Kulmirzayeva, D., Prabakaran, I. and Javaid, M., 2025. Retrospective analysis of tuberculosis incidence in Kazakhstan for 2000-2023. Journal of Health Development, 60(1), pp.17-23.
49. Kumar, N.P., & Babu, S. (2023). Impact of diabetes mellitus on immunity to latent tuberculosis infection. Frontiers in Clinical Diabetes and Healthcare, 4, 1095467.
50. Kwak SH, Jeong D, Mok J, Jeon D, Kang H-Y, Kim HJ, et al. (2023) Association between diabetes mellitus and cause of death in patients with tuberculosis: A Korean nationwide cohort study. PLoS ONE 18(12): e0295556.

Referensi Tuberkulosis C-F

1. Carr, B.Z., Briganti, E.M., Musemburi, J., Jenkin, G.A. and Denholm, J.T., 2022. Effect of chronic kidney disease on all-cause mortality in tuberculosis disease: an Australian cohort study. BMC Infectious Diseases, 22(1), p.116.
2. Cegielski, J.P. and McMurray, D.N., 2004. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. The international journal of tuberculosis and lung disease, 8(3), pp.286-298.
3. Chakhaia, T., Blumberg, H.M., Kempker, R.R., Luo, R., Dzidzikashvili, N., Chincharauli, M., Tukvadze, N., Avaliani, Z., Stauber, C. and Magee, M.J., 2025. Lack of weight gain and increased mortality during and after treatment among adults with drug-resistant tuberculosis: a retrospective cohort study in Georgia, 2009–2020. ERJ Open Research.
4. Chang, J.T., Dou, H.Y., Yen, C.L., Wu, Y.H., Huang, R.M., Lin, H.J., Su, I.J. and Shieh, C.C., 2011. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. Journal of the Formosan Medical Association, 110(6), pp.372-381.
5. Charles, F., Lin, Y.D., Greig, J., Gurra, S., Morikawa, R., Graham, S.M. and Maha, A., 2024. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action, 14(3), pp.85-90.
6. Chaw L, Jeludin NH, Thu K. Prevalence and risk factors associated with tuberculosis mortality in Brunei Darussalam. Asian Pac J Trop Med 2023; 16(1): 9-15.
7. Chaw, L., Hamid, R.A., Koh, K.S. and Thu, K., 2022. Contact investigation of tuberculosis in Brunei Darussalam: Evaluation and risk factor analysis. BMJ open respiratory research, 9(1).
8. Chaw, L., Liew, S.Q. and Wong, J., 2022. Association between climate variables and pulmonary tuberculosis incidence in Brunei Darussalam. Scientific Reports, 12(1), p.8775.
9. Chen, R.T., Liu, C.Y., Lin, S.Y., Shu, C.C. and Sheng, W.H., 2024. The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription. Scientific Reports, 14(1), p.5631.
10. Chen, S.Y., 2024. Trends and annual percentage changes in tuberculosis mortality estimated by Joinpoint regression and age-period-cohort analyses, Taiwan, 1978–2022. Scientific Reports, 14(1), p.29101.
11. Chen, X., Zhou, J., Yuan, Q., Zhang, R., Huang, C. and Li, Y., 2024. Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model–a systematic review and meta-analysis. BMC Public Health, 24(1), p.163.
12. Chen, S., Zhang, W., Zheng, Z., Shao, X., Yang, P., Yang, X. and Nan, K., 2023. Unraveling genetic causality between type 2 diabetes and pulmonary tuberculosis on the basis of Mendelian randomization. Diabetology & Metabolic Syndrome, 15(1), pp.1-9.
13. Chen, Z., Liu, Q., Song, R., Zhang, W., Wang, T., Lian, Z., Sun, X. and Liu, Y., 2021. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocrine Disorders, 21(1), p.123.
14. Chen, C.C., Chiang, C.Y., Pan, S.C., Wang, J.Y. and Lin, H.H., 2015. Health system delay among patients with tuberculosis in Taiwan: 2003–2010. BMC infectious diseases, 15, pp.1-9.
15. Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, et al. (2015) The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis. PLoS ONE 10(3): e0121698. doi:10.1371/journal. pone.0121698.
16. Chidambaram, V., Gupte, A., Wang, J.Y., Golub, J.E. and Karakousis, P.C., 2021. The impact of hypertension and use of calcium channel blockers on tuberculosis treatment outcomes. Clinical Infectious Diseases, 73(9), pp.e3409-e3418.
17. Choi, H., Han, K., Jung, J.H., Park, S.H., Kim, S.H., Kang, H.K., Sohn, J.W., Shin, D.W. and Lee, H., 2023. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clinical Infectious Diseases, 76(3), pp.e973-e981.
18. Choi, H., Yoo, J.E., Han, K., Choi, W., Rhee, S.Y., Lee, H. and Shin, D.W., 2021. Body mass index, diabetes, and risk of tuberculosis: a retrospective cohort study. Frontiers in nutrition, 8, p.739766.
19. Chu, A.L., Lecca, L.W., Calderón, R.I., Contreras, C.C., Yataco, R.M., Zhang, Z., Becerra, M.C., Murray, M.B. and Huang, C.C., 2021. Smoking cessation in tuberculosis patients and the risk of tuberculosis infection in child household contacts. Clinical Infectious Diseases, 73(8), pp.1500-1506.
20. Chung, C., Lee, S.W., Jeong, D., Choi, H., Sohn, H., Jeon, D. and Kang, Y.A., 2025. Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011–2020. Journal of Infection and Public Health, 18(5), p.102723.
21. Chung, C., Lee, K.N., Han, K., Park, J., Shin, D.W. and Lee, S.W., 2024. Association between alcohol consumption and risk of developing tuberculosis in patients with diabetes: a nationwide retrospective cohort study. Respiratory Research, 25(1), p.420.
22. Chung, E., Jeong, D., Mok, J., Jeon, D., Kang, H.Y., Kim, H., Kim, H., Choi, H. and Kang, Y.A., 2024. Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study. The Korean Journal of Internal Medicine, 39(2), p.306.
23. Clark, R.A., Mukandavire, C., Portnoy, A., Weerasuriya, C.K., Deol, A., Scarponi, D., Iskauskas, A., Bakker, R., Quaife, M., Malhotra, S. and Gebreselassie, N., 2023. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study. The Lancet Global Health, 11(4), pp.e546-e555.
24. d'Elbée, M., Harker, M., Mafirakureva, N., Nanfuka, M., Nguyet, M.H.T.N., Taguebue, J.V., Moh, R., Khosa, C., Mustapha, A., Mwanga-Amumpere, J. and Borand, L., 2024. Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study. EClinicalMedicine, 70, p.102528.
25. Dasan, B., Rajamanickam, A., Pandiarajan, A.N., Shanmugam, S., Nott, S. and Babu, S., 2025. Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis. Microbiology Spectrum, 13(1), pp.e01445-24.
26. Dodd, P.J., Yuen, C.M., Jayasooriya, S.M., van der Zalm, M.M. and Seddon, J.A., 2021. Quantifying the global number of tuberculosis survivors: a modelling study. The Lancet Infectious Diseases, 21(7), pp.984-992.
27. Dos Santos, P.C.P., Messina, N.L., de Oliveira, R.D., da Silva, P.V., Puga, M.A.M., Dalcolmo, M., Dos Santos, G., de Lacerda, M.V.G., Jardim, B.A., e Val, F.F.D.A. and Curtis, N., 2024. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. The Lancet Infectious Diseases, 24(6), pp.594-601.
28. Du, Z.X., Ren, Y.Y., Wang, J.L., Li, S.X., Hu, Y.F., Wang, L., Chen, M.Y., Li, Y., Hu, C.M. and Yang, Y.F., 2024. The potential association between metabolic disorders and pulmonary tuberculosis: a Mendelian randomization study. European Journal of Medical Research, 29(1), p.277.
29. Dye, C., Garnett, G.P., Sleeman, K. and Williams, B.G., 1998. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. The Lancet, 352(9144), pp.1886-1891.
30. Dye, C., Watt, C.J., Bleed, D.M., Hosseini, S.M. and Raviglione, M.C., 2005. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Jama, 293(22), pp.2767-2775.
31. Eksombatchai, D., Jeong, D., Mok, J., Jeon, D., Kang, H.Y., Kim, H.J., Kim, H.S., Choi, H. and Kang, Y.A., 2023. Sex differences in the impact of diabetes mellitus on tuberculosis recurrence: a retrospective national cohort study. International Journal of Infectious Diseases, 127, pp.1-10.
32. Esmail, A., Randall, P., Oelofse, S. et al. Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial. Nat Med 29, 1009–1016 (2023).
33. Evans, D., Hirasen, K., Casalme, D.J., Gler, M.T., Gupta, A. and Juneja, S., 2024. Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines. IJTLD open, 1(6), pp.242-249.
34. Fadhilah, A.N. and Wikandari, R.J., 2024. The relationship between the length of treatment for pulmonary tuberculosis patients in the intensive phase and hemoglobin levels. Journal of Indonesian Medical Laboratory and Science, 5(2), pp.140-149.
35. Fahdhienie, F., Mudatsir, M., Abidin, T.F. and Nurjannah, N., 2024. Risk factors of pulmonary tuberculosis in Indonesia: a case-control study in a high disease prevalence region. Narra J, 4(2), p.e943.
36. Foster, N., Cunnama, L., McCarthy, K., Ramma, L., Siapka, M., Sinanovic, E., Churchyard, G., Fielding, K., Grant, A.D. and Cleary, S., 2021. Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis. Plos one, 16(5), p.e0251547.
37. Franco, J.V., Bongaerts, B., Metzendorf, M.I., Risso, A., Guo, Y., Silva, L.P., Boeckmann, M., Schlesinger, S., Damen, J.A., Richter, B. and Baddeley, A., 2024. Diabetes as a risk factor for tuberculosis disease. The Cochrane database of systematic reviews, 8, p.CD016013.
38. Franke, M.A., Emmrich, J.V., Ranjaharinony, F., Ravololohanitra, O.G., Andriamasy, H.E., Knauss, S. and Muller, N., 2024. A cross-sectional analysis of the effectiveness of a nutritional support programme for people with tuberculosis in Southern Madagascar using secondary data from a non-governmental organisation. Infectious Diseases of Poverty, 13(1), p.13.
39. Fu, H., Lin, H.H., Hallett, T.B. and Arinaminpathy, N., 2018. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting. Vaccine, 36(39), pp.5902-5909.
40. Fu, H., Lin, HH., Hallett, T.B. et al. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis 20, 191 (2020). https://doi.org/10.1186/s12879-020-4914-2
41. Fuady, A., Hutanamon, T., Herlinda, O., Luntungan, N. and Wingfield, T., 2024. Achieving universal social protection for people with tuberculosis. The Lancet Public Health, 9(5), pp.e339-e344.
42. Furin, J., Cox, H., & Pai, M. (2019). Tuberculosis. Lancet (London, England), 393(10181), 1642–1656.